CF
TEVA icon

Centaurus Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Centaurus Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
34,881
-5,346
-13% -$178K 0.05% 364
2026
Q1 		$1.21M Sell
40,227
-4,105
-9% -$132K 0.06% 299
2025
Q4 		$1.38M Sell
44,332
-7,280
-14% -$179K 0.06% 274
2025
Q3 		$1.04M Buy
51,612
+10,384
+25% +$182K 0.05% 320
2025
Q2 		$691K Sell
41,228
-3,626
-8% -$58.5K 0.04% 378
2025
Q1 		$689K Buy
44,854
+9,575
+27% +$171K 0.04% 367
2024
Q4 		$778K Buy
35,279
+17,388
+97% +$316K 0.05% 319
2024
Q3 		$322K Buy
17,891
+3,876
+28% +$67.8K 0.02% 516
2024
Q2 		$228K Buy
+14,015
New +$216K 0.02% 566
2023
Q2 		– Sell
-12,448
Closed -$110K – 905
2023
Q1 		$110K Sell
12,448
-2,195
-15% -$21.7K 0.01% 826
2022
Q4 		$134K Sell
14,643
-54
-0.4% -$471 0.01% 707
2022
Q3 		$119K Buy
14,697
+71
+0.5% +$628 0.01% 749
2022
Q2 		$110K Sell
14,626
-380
-3% -$3.31K 0.01% 775
2022
Q1 		$141K Sell
15,006
-2,000
-12% -$16.7K 0.01% 764
2021
Q4 		$136K Buy
17,006
+700
+4% +$6.32K 0.01% 797
2021
Q3 		$159K Sell
16,306
-500
-3% -$4.68K 0.01% 719
2021
Q2 		$166K Buy
16,806
+302
+2% +$3.2K 0.01% 725
2021
Q1 		$190K Buy
16,504
+6,115
+59% +$70.1K 0.02% 620
2020
Q4 		$100K Sell
10,389
-400
-4% -$3.83K 0.01% 756
2020
Q3 		$97K Hold
10,789
– – 0.01% 630
2020
Q2 		$133K Sell
10,789
-8
-0.1% -$90 0.02% 529
2020
Q1 		$97K Buy
10,797
+8
+0.1% +$82 0.02% 499
2019
Q4 		$106K Buy
+10,789
New +$96.3K 0.01% 607
2018
Q3 		– Sell
-17,572
Closed -$427K – 1889
2018
Q2 		$427K Buy
+17,572
New +$358K 0.06% 331

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Centaurus Financial's TEVA Position: Q2 2026 in Review

Centaurus Financial reduced its Teva Pharmaceuticals (TEVA) stake by 13% in Q2 2026, selling an estimated $178K and leaving 34,881 shares worth $1.18M. The position accounts for 0.05% of the portfolio, ranked #364.

Centaurus Financial first reported a position in TEVA in Q2 2018 and has held it in 24 quarters since. The position peaked at $1.38M in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Centaurus Financial held 34,881 shares of Teva Pharmaceuticals worth $1.18M as of Q2 2026.
  • Centaurus Financial sold 5,346 Teva Pharmaceuticals shares in Q2 2026, an estimated $178K.
  • Teva Pharmaceuticals made up 0.05% of Centaurus Financial's portfolio in Q2 2026, its #364 holding.
  • Centaurus Financial first reported a position in Teva Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
  • Centaurus Financial's Teva Pharmaceuticals position peaked at $1.38M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.